ZA974366B - Potassium, sodium and tris oxaprozin salt pharmaceutical formulations. - Google Patents

Potassium, sodium and tris oxaprozin salt pharmaceutical formulations.

Info

Publication number
ZA974366B
ZA974366B ZA9704366A ZA974366A ZA974366B ZA 974366 B ZA974366 B ZA 974366B ZA 9704366 A ZA9704366 A ZA 9704366A ZA 974366 A ZA974366 A ZA 974366A ZA 974366 B ZA974366 B ZA 974366B
Authority
ZA
South Africa
Prior art keywords
sodium
potassium
pharmaceutical formulations
salt pharmaceutical
tris
Prior art date
Application number
ZA9704366A
Other languages
English (en)
Inventor
Mark E Adams
Subhash Desai
Aziz Karim
Kalidas Paul
Douglas J Schaaf
David J Zold
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of ZA974366B publication Critical patent/ZA974366B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/4211,3-Oxazoles, e.g. pemoline, trimethadione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
ZA9704366A 1996-05-20 1997-05-20 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations. ZA974366B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1903396P 1996-05-20 1996-05-20

Publications (1)

Publication Number Publication Date
ZA974366B true ZA974366B (en) 1998-05-20

Family

ID=21791076

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704366A ZA974366B (en) 1996-05-20 1997-05-20 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations.

Country Status (20)

Country Link
US (1) US6030643A (fr)
EP (1) EP0901372B1 (fr)
JP (1) JP4185974B2 (fr)
KR (1) KR20000015865A (fr)
CN (1) CN1129429C (fr)
AT (1) ATE299699T1 (fr)
AU (1) AU718030B2 (fr)
BR (1) BR9710448A (fr)
CA (1) CA2255064C (fr)
CZ (1) CZ370298A3 (fr)
DE (1) DE69733752T2 (fr)
ES (1) ES2248850T3 (fr)
IL (1) IL126998A (fr)
NO (1) NO985414L (fr)
NZ (1) NZ332861A (fr)
PL (1) PL330145A1 (fr)
RU (1) RU2197244C2 (fr)
TW (1) TW586929B (fr)
WO (1) WO1997044022A1 (fr)
ZA (1) ZA974366B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022939A1 (fr) * 1999-09-29 2001-04-05 Fmc Corporation Granulations par cellulose hydrolyzee de sels de medicaments
US6497157B1 (en) * 1999-11-29 2002-12-24 Distek, Inc. Intrinsic dissolution apparatus with stationary sample holder
FR2828810B1 (fr) * 2001-08-27 2005-10-07 Lvmh Rech Composition cosmetique a effet tenseur contenant un polymere d'origine naturelle et un agent hydratant polyhydroxyle
KR100574554B1 (ko) * 2004-05-28 2006-04-27 한미약품 주식회사 니아신의 경구투여용 서방성 조성물
AU2006228869A1 (en) * 2005-03-30 2006-10-05 Astion Pharma A/S Oxaprozin or a closely related compound for the treatment of eczema
US20060229347A1 (en) * 2005-03-30 2006-10-12 Astion Development A/S Treatment of eczemas
WO2006130726A2 (fr) * 2005-06-01 2006-12-07 Teva Pharmaceutical Industries, Ltd. Utilisation du ladostigil pour traiter la sclerose en plaques
TW200836774A (en) * 2007-02-01 2008-09-16 Takeda Pharmaceutical Solid preparation
EA201491749A1 (ru) * 2012-03-22 2015-01-30 ТРАНСТЕК ФАРМА, ЭлЭлСи Трис-(гидроксиметил)аминометановые соли низкомолекулярного агониста glp1r, их фармацевтические композиции и применение
EP3275433A1 (fr) 2016-07-29 2018-01-31 Som Innovation Biotech S.L. Composition à libération prolongée comprenant du tolcapone micronisé

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts
US4190584A (en) * 1976-08-13 1980-02-26 John Wyeth & Brother Limited Process for preparing oxazoles
GB2097389B (en) * 1981-04-28 1984-11-28 Wyeth John & Brother Ltd Oxazole derivative
IE52909B1 (en) * 1981-04-28 1988-04-13 Wyeth John & Brother Ltd Oxazole derivatives
US4385049A (en) * 1981-05-12 1983-05-24 K-V Pharmaceutical Company Stable high internal phase ratio topical emulsions
US4599359A (en) * 1982-12-09 1986-07-08 Stephen A. Cooper Hydroxyzine-containing analgesic combinations
GB8329326D0 (en) * 1983-11-03 1983-12-07 Wyeth John & Brother Ltd Oxazole derivatives
IT1204751B (it) * 1986-01-03 1989-03-10 Therapicon Srl Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico,loro preparazione ed utilizzo in composizioni farmaceutiche
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US5059626A (en) * 1988-07-25 1991-10-22 Applied Analytical Industries, Inc. Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
WO1992007561A1 (fr) * 1990-10-30 1992-05-14 Ss Pharmaceutical Co., Ltd. Preparation d'un gel anti-inflammatoire et analgesique
CA2170485C (fr) * 1993-09-07 2000-11-07 Sekhar Mitra Compositions renfermant un sel d'acide propionique d'amino-acide, agents anti-inflammatoires non steroidiques utilises avec la cafeine
AU7604094A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive

Also Published As

Publication number Publication date
CN1129429C (zh) 2003-12-03
CZ370298A3 (cs) 1999-05-12
WO1997044022A1 (fr) 1997-11-27
ATE299699T1 (de) 2005-08-15
BR9710448A (pt) 1999-08-17
NO985414L (no) 1999-01-19
RU2197244C2 (ru) 2003-01-27
US6030643A (en) 2000-02-29
NZ332861A (en) 2000-08-25
IL126998A0 (en) 1999-09-22
EP0901372B1 (fr) 2005-07-20
CA2255064A1 (fr) 1997-11-27
CA2255064C (fr) 2006-10-10
EP0901372A1 (fr) 1999-03-17
JP2001503734A (ja) 2001-03-21
KR20000015865A (ko) 2000-03-15
DE69733752T2 (de) 2006-06-01
JP4185974B2 (ja) 2008-11-26
AU3059797A (en) 1997-12-09
ES2248850T3 (es) 2006-03-16
NO985414D0 (no) 1998-11-20
TW586929B (en) 2004-05-11
AU718030B2 (en) 2000-04-06
IL126998A (en) 2003-12-10
DE69733752D1 (de) 2005-08-25
PL330145A1 (en) 1999-04-26
CN1225580A (zh) 1999-08-11

Similar Documents

Publication Publication Date Title
EA199800772A1 (ru) Производные 6-фенилпиридил-2-амина
MX9705569A (es) Inhibidores de adhesion celular.
SG158733A1 (en) Cell adhesion inhibitors
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
MX9800348A (es) Inhibidores de adhesion celular.
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
ZA943744B (en) Therapeutic substituted guanidines
GB2288732B (en) Pharmaceutical compositions
DE69905170D1 (en) Thiazolopyrimidinderivate
HK1025737A1 (en) Treatment of multiple sclerosis through ingestion of copolymer-1
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
YU13301A (sh) Muskarinski agonisti i antagonisti
ZA974366B (en) Potassium, sodium and tris oxaprozin salt pharmaceutical formulations.
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
EP1032556A4 (fr) Composes pharmaceutiquement actifs et procedes d'utilisation
NZ330944A (en) Peptide derivatives
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
NZ217356A (en) Benzamide derivatives and pharmaceutical compositions
MD457G2 (ro) Derivaţi noi de naftiridină, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizarea lor ca medicamente de antireproducere
GB9921985D0 (en) Medicaments containing pantothenic acid
MX9802809A (es) Ureasa para el tratamiento de infecciones de helicobacter pylori.